Exhibit 99.2

MEDCATH CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

	Three Months Ended						Twelve Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Net revenue	$	110,527		$	103,600		$	442,496		$	419,733
Operating expenses:
Personnel expense		37,355			33,926			151,990			141,315
Medical supplies expense		27,328			27,299			113,588			111,253
Bad debt expense		13,456			12,692			46,887			39,068
Other operating expenses		26,372			23,317			104,327			90,603
Pre-opening expenses		—			2,223			866			3,563
Depreciation		6,277			6,305			26,895			22,818
Amortization		8			867			32			891
Impairment of goodwill		—			51,500			—			51,500
Impairment of property and equipment		30,211			—			67,776			—
Loss on disposal of property, equipment and other assets		21			87			57			192
Total operating expenses		141,028			158,216			512,418			461,203
Loss from operations		(30,501	)		(54,616	)		(69,922	)		(41,470	)
Other income (expenses):
Interest expense		(1,229	)		(688	)		(4,548	)		(3,746	)
Loss on early extinguishment of debt		—			—			—			(6,702	)
Interest and other income, net		(59	)		7			84			217
Loss on note receivable		—			—			(1,507	)		—
Equity in net earnings of unconsolidated affiliates		2,198			2,013			9,121			9,057
Total other income (expense), net		910			1,332			3,150			(1,174	)
Loss from continuing operations before income taxes		(29,591	)		(53,284	)		(66,772	)		(42,644	)
Income tax benefit		(10,317	)		(1,263	)		(26,316	)		(362	)
Loss from continuing operations		(19,274	)		(52,021	)		(40,456	)		(42,282	)
Income from discontinued operations, net of taxes		4,810			1,061			5,028			9,527
Net loss		(14,464	)		(50,960	)		(35,428	)		(32,755	)
Less: Net income attributable to noncontrolling interest		(6,671	)		(7,646	)		(12,389	)		(17,527	)
Net loss attributable to MedCath Corporation	$	(21,135	)	$	(58,606	)	$	(47,817	)	$	(50,282	)
Amounts attributable to MedCath Corporation common stockholders:
Loss from continuing operations, net of taxes	$	(25,169	)		(53,214	)	$	(51,402	)	$	(51,655	)
Income (loss) from discontinued operations, net of taxes		4,034			(5,392	)		3,585			1,373
Net loss	$	(21,135	)	$	(58,606	)	$	(47,817	)	$	(50,282	)
(Loss) earnings per share, basic
Loss from continuing operations attributable to MedCath Corporation common stockholders	$	(1.26	)	$	(2.70	)	$	(2.59	)	$	(2.62	)
Income from discontinued operations attributable to MedCath Corporation common stockholders		0.20			(0.27	)		0.18			0.07
Loss per share, basic	$	(1.06	)	$	(2.97	)	$	(2.41	)	$	(2.55	)
(Loss) earnings per share, diluted
Loss from continuing operations attributable to MedCath Corporation common stockholders	$	(1.26	)	$	(2.70	)	$	(2.59	)	$	(2.62	)
Income from discontinued operations attributable to MedCath Corporation common stockholders		0.20			(0.27	)		0.18			0.07
Loss per share, diluted	$	(1.06	)	$	(2.97	)	$	(2.41	)	$	(2.55	)
Weighted average number of shares, basic		19,898			19,740			19,842			19,684
Dilutive effect of stock options and restricted stock		—			—			—			—
Weighted average number of shares, diluted		19,898			19,740			19,842			19,684

MEDCATH CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

	September 30,			September 30,
	2010			2009
	(Unaudited)
Current assets:
Cash and cash equivalents	$	34,835		$	28,267
Accounts receivable, net		48,540			49,314
Income tax receivable		6,188			—
Medical supplies		13,481			13,001
Deferred income tax assets		13,327			12,161
Prepaid expenses and other current assets		13,583			13,077
Current assets of discontinued operations		38,356			61,045
Total current assets		168,310			176,865
Property and equipment, net		224,082			302,717
Other assets		15,653			24,796
Deferred income tax assets		8,717			—
Non-current assets of discontinued operations		78,330			86,070
Total assets	$	495,092		$	590,448
Current liabilities:
Accounts payable	$	19,267		$	26,838
Income tax payable		—			297
Accrued compensation and benefits		18,153			14,314
Other accrued liabilities		18,291			21,750
Current portion of long-term debt and obligations
under capital leases		16,672			21,074
Current liabilities of discontinued operations		28,130			32,358
Total current liabilities		100,513			116,631
Long-term debt		52,500			66,563
Obligations under capital leases		6,500			4,255
Deferred income tax liabilities		—			13,874
Other long-term obligations		5,053			8,533
Long-term liabilities of discontinued operations		35,968			36,062
Total liabilities		200,534			245,918
Commitments and contingencies
Redeemable noncontrolling interest		11,534			7,448
Stockholders’ equity:
Preferred stock, $0.01 par value, 10,000,000 shares authorized; none issued		—			—
Common stock, $0.01 par value, 50,000,000 shares authorized; 22,423,666 issued and 20,469,305 outstanding at September 30, 2010; 22,104,917 issued and 20,150,556 outstanding at September 30, 2009		216			216
Paid-in capital		457,725			455,259
Accumulated deficit		(139,237	)		(91,420	)
Accumulated other comprehensive loss		(444	)		(360	)
Treasury stock, at cost; 1,954,361 shares at September 30, 2010 1,954,361 shares at September 30, 2009		(44,797	)		(44,797	)
Total MedCath Corporation stockholders’ equity		273,463			318,898
Noncontrolling interest		9,561			18,184
Total equity		283,024			337,082
Total liabilities and equity	$	495,092		$	590,448

MEDCATH CORPORATION
SELECTED OPERATING DATA
(In thousands, except per share data and selected operating data)
(Unaudited)

	Three Months Ended September 30,									Twelve Months Ended September 30,
	2010			2009			% Change			2010			2009			% Change
Statement of Operations Data:
Net revenue	$	110,527		$	103,600			6.7	%	$	442,496		$	419,733			5.4	%
Adjusted EBITDA (1)	$	9,117		$	8,166			11.6	%	$	32,619		$	46,734			(30.2	)%
Loss from operations	$	(30,501	)	$	(54,616	)		44.2	%	$	(69,922	)	$	(41,470	)		(68.6	)%
Loss from continuing operations, net of taxes	$	(25,169	)	$	(53,214	)		52.7	%	$	(51,402	)	$	(51,655	)		0.5	%
Loss per share from continuing operations, basic	$	(1.26	)	$	(2.70	)		53.3	%	$	(2.59	)	$	(2.62	)		1.1	%
Loss per share from continuing operations, diluted	$	(1.26	)	$	(2.70	)		53.3	%	$	(2.59	)	$	(2.62	)		1.1	%

(1) See Supplemental Financial Disclosure-Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.

	Three Months Ended September 30,															Twelve Months Ended September 30,
										2010															2010
							%			Same			%									%			Same			%
	2010			2009			Change			Facility			Change			2010			2009			Change			Facility			Change
Selected Operating Data(a):
Number of hospitals		6			5						5						6			5						5
Licensed beds(c)		541			471						471						541			471						471
Staffed and available beds(d)		455			385						385						455			385						385
Admissions(e)		5,255			4,917			6.9	%		4,775			(2.9	)%		21,998			19,931			10.4	%		20,330			2.0	%
Adjusted admissions(f)		8,140			7,218			12.8	%		7,218			0.0	%		32,567			28,692			13.5	%		29,462			2.7	%
Patient days(g)		19,156			18,032			6.2	%		17,352			(3.8	)%		82,105			75,817			8.3	%		75,831			0.0	%
Adjusted patient days(h)		29,788			26,481			12.5	%		26,324			(0.6	)%		121,940			109,281			11.6	%		110,262			0.9	%
Average length of stay (days)(i)		3.65			3.67			(0.5	)%		3.63			(1.1	)%		3.73			3.80			(1.8	)%		3.73			(1.8	)%
Occupancy(j)		45.8	%		50.9	%					49.0	%					49.4	%		54.0	%					54.0	%
Inpatient catheterization procedures(k)		2,431			2,387			1.8	%		2,373			(0.6	)%		10,219			10,167			0.5	%		9,962			(2.0	)%
Inpatient surgical procedures(l)		1,241			1,251			(0.8	)%		1,127			(9.9	)%		5,234			5,064			3.4	%		4,895			(3.3	)%
Hospital net revenue	$	107,375		$	98,533			9.0	%	$	99,619			1.1	%	$	428,122		$	400,170			7.0	%	$	401,050			0.2	%
Combined Operating Data(b):
Number of hospitals		8			7						7						8			7						7
Licensed beds(c)		708			638						638						708			638						638
Staffed and available beds(d)		619			548						549						619			548						549
Admissions(e)		7,816			7,356			6.3	%		7,336			(0.3	)%		32,360			31,132			3.9	%		30,692			(1.4	)%
Adjusted admissions(f)		12,350			11,285			9.4	%		11,428			1.3	%		49,861			46,899			6.3	%		46,756			(0.3	)%
Patient days(g)		27,243			25,920			5.1	%		25,439			(1.9	)%		114,989			110,366			4.2	%		108,715			(1.5	)%
Adjusted patient days(h)		42,974			39,399			9.1	%		39,510			0.3	%		176,268			164,473			7.2	%		164,590			0.1	%
Average length of stay (days)(i)		3.49			3.52			(0.9	)%		3.47			(1.4	)%		3.55			3.55			0.0	%		3.54			(0.3	)%
Occupancy(j)		47.8	%		51.4	%					50.4	%					50.9	%		55.2	%					54.3	%
Inpatient catheterization procedures(k)		3,031			3,003			0.9	%		2,973			(1.0	)%		12,925			13,137			(1.6	)%		12,668			(3.6	)%
Inpatient surgical procedures(l)		1,864			1,826			2.1	%		1,750			(4.2	)%		7,570			7,456			1.5	%		7,231			(3.0	)%
Hospital net revenue	$	147,424		$	137,119			7.5	%	$	139,668			1.9	%	$	593,461		$	560,848			5.8	%	$	566,389			1.0	%

(a)	Selected operating data includes consolidated hospitals in operation as of the end of the period reported in continuing operations but does not include hospitals which are accounted for using the equity method or as discontinued operations in our consolidated financial statements. Same facility for the three and twelve months ended September 30, 2010 exclude the results of Hualapai Mountain Medical Center.
(b)	Combined operating data includes hospitals in operation as of the end of the period reported in continuing operations including hospitals which are accounted for using the equity method in our consolidated financial statements.
(c)	Licensed beds represent the number of beds for which the appropriate state agency licenses a facility regardless of whether the beds are actually available for patient use.
(d)	Staffed and available beds represent the number of beds that are readily available for patient use at the end of the period.
(e)	Admissions represent the number of patients admitted for inpatient treatment.
(f)	Adjusted admissions is a general measure of combined inpatient and outpatient volume. We computed adjusted admissions by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by admissions.
(g)	Patient days represent the total number of days of care provided to inpatients.
(h)	Adjusted patient days is a general measure of combined inpatient and outpatient volume. We computed adjusted patient days by dividing gross patient revenue by gross inpatient revenue and then multiplying the quotient by patient days.
(i)	Average length of stay (days) represents the average number of days inpatients stay in our hospitals.
(j)	We computed occupancy by dividing patient days by the number of days in the period and then dividing the quotient by the number of staffed and available beds.
(k)	Inpatients with a catheterization procedure represent the number of inpatients with a procedure performed in one of the hospitals’ catheterization labs during the period.
(l)	Inpatient surgical procedures represent the number of surgical procedures performed on inpatients during the period.

SUPPLEMENTAL FINANCIAL DISCLOSURE — RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
(Unaudited)

The following table reconciles the loss from continuing operations, net of taxes attributable to MedCath Corporation’s common stockholders as derived directly from MedCath Corporation’s consolidated financial statements to Adjusted EBITDA for the three and twelve months ended September 30, 2010 and 2009.

	Three Months Ended						Twelve Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
	(in thousands)						(in thousands)
Loss from continuing operations, net of taxes	$	(25,169	)	$	(53,214	)	$	(51,402	)	$	(51,655	)
Add:
Income tax benefit		(10,317	)		(1,263	)		(26,316	)		(362	)
Net income attributable to noncontrolling interest		5,895			1,193			10,946			9,374
Equity in net earnings of unconsolidated affiliates		(2,198	)		(2,013	)		(9,121	)		(9,057	)
Interest and other income, net		59			(7	)		(84	)		(217	)
Loss on note receivable		—			—			1,507			—
Loss on early extinguishment of debt		—			—			—			6,702
Interest expense		1,229			688			4,548			3,746
Loss on disposal of property, equipment and other assets		21			87			57			192
Impairment of property and equipment		30,211			—			67,776			—
Impairment of goodwill		—			51,500			—			51,500
Amortization		8			867			32			891
Depreciation		6,277			6,305			26,895			22,818
Pre-opening expenses		—			2,223			866			3,563
Share-based compensation expense		772			322			3,151			2,390
Professional fees for strategic plans		2,590			—			4,025			—
DSH and Medicaid adjustments		—			1,478			—			4,543
Professional fees for internal assessment		—			—			—			1,106
Stent procedure penalty		—			—			—			840
Other non-recurring items		(261	)		—			(261	)		—
Severance expense		—			—			—			360
Adjusted EBITDA	$	9,117		$	8,166		$	32,619		$	46,734

The following table reconciles MedCath Corporation’s diluted loss per share from continuing operations, net of taxes attributable to MedCath Corporations common stockholders as derived directly from MedCath’s consolidated financial statements to Adjusted diluted earnings per share from continuing operations for the three and twelve months ended September 30, 2010 and 2009.

	Three Months Ended						Twelve Months Ended
	September 30,						September 30,
	2010			2009			2010			2009
Diluted loss per share	$	(1.26	)	$	(2.70	)	$	(2.59	)	$	(2.62	)
Add:
Impairment of property and equipment		0.92			—			2.15			—
Impairment of goodwill		—			2.61			—			2.61
Loss on note receivable		—			—			0.05			—
DSH and Medicaid adjustments		—			0.04			—			0.13
Termination of management contract		—			0.03			—			0.03
Professional fees for strategic plans		0.08			—			0.13			—
Professional fees for internal assessments		—			—			—			0.03
Severance expense		—			—			—			0.01
Loss on early extinguishment of debt		—			—			—			0.22
Other non-recurring items		(0.01	)		—			0.03			—
Non-cash minority interest		0.15			—			0.15			—
Tax valuation		0.14			—			0.14			—
Share-based compensation expense		0.02			0.01			0.10			0.08
Pre-opening expense		—			0.05			0.02			0.09
Adjusted diluted earnings per share	$	0.04		$	0.04		$	0.18		$	0.58